Form 8-K - Current report:
SEC Accession No. 0000950170-25-073711
Filing Date
2025-05-16
Accepted
2025-05-16 17:21:37
Documents
11
Period of Report
2025-05-14
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rkda-20250514.htm   iXBRL 8-K 57177
  Complete submission text file 0000950170-25-073711.txt   174218

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rkda-20250514.xsd EX-101.SCH 24852
13 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20250514_htm.xml XML 4670
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37383 | Film No.: 25960656
SIC: 1311 Crude Petroleum & Natural Gas
(CF Office: 01 Energy & Transportation)